BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10708189)

  • 1. Site-specific effect of guanosine 3',5'-cyclic monophosphate phosphodiesterase inhibition in isolated lamb lungs.
    Steinhorn RH; Gordon JB; Tod ML
    Crit Care Med; 2000 Feb; 28(2):490-5. PubMed ID: 10708189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension.
    Weimann J; Ullrich R; Hromi J; Fujino Y; Clark MW; Bloch KD; Zapol WM
    Anesthesiology; 2000 Jun; 92(6):1702-12. PubMed ID: 10839922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.
    Thusu KG; Morin FC; Russell JA; Steinhorn RH
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1605-10. PubMed ID: 7582302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs.
    Ichinose F; Adrie C; Hurford WE; Zapol WM
    J Appl Physiol (1985); 1995 Apr; 78(4):1288-95. PubMed ID: 7615435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E4021, a selective phosphodiesterase 5 inhibitor, potentiates the vasodilator effect of inhaled nitric oxide in isolated perfused rat lungs.
    Ohnishi M; Oka M; Muramatsu M; Sato K; Kira S; Fukuchi Y
    J Cardiovasc Pharmacol; 1999 Apr; 33(4):619-24. PubMed ID: 10218733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective pulmonary vasodilation induced by aerosolized zaprinast.
    Ichinose F; Adrie C; Hurford WE; Bloch KD; Zapol WM
    Anesthesiology; 1998 Feb; 88(2):410-6. PubMed ID: 9477062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled nitric oxide potentiates actions of adenosine but not of sodium nitroprusside in experimental pulmonary hypertension.
    Patterson KW; Deb B; Kavanagh BP; Pearl RG
    Pharmacology; 1999 May; 58(5):246-51. PubMed ID: 10087465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension.
    Deb B; Bradford K; Pearl RG
    Crit Care Med; 2000 Mar; 28(3):795-9. PubMed ID: 10752832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
    Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
    Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoconstriction increases pulmonary nitric oxide synthesis and circulating cyclic GMP.
    Wilson PS; Thompson WJ; Moore TM; Khimenko PL; Taylor AE
    J Surg Res; 1997 Jun; 70(1):75-83. PubMed ID: 9228932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy with zaprinast and inhaled nitric oxide abolishes hypoxic pulmonary hypertension.
    Nagamine J; Hill LL; Pearl RG
    Crit Care Med; 2000 Jul; 28(7):2420-4. PubMed ID: 10921573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary responses to selective phosphodiesterase-5 and phosphodiesterase-3 inhibitors.
    Matot I; Gozal Y
    Chest; 2004 Feb; 125(2):644-51. PubMed ID: 14769749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous Zaprinast and inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of acute respiratory distress syndrome.
    Adrie C; Holzmann A; Hirani WM; Zapol WM; Hurford WE
    Anesthesiology; 2000 Aug; 93(2):422-30. PubMed ID: 10910492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase-3 inhibition prevents the increase in pulmonary vascular resistance following inhaled nitric oxide withdrawal in lambs.
    Thelitz S; Oishi P; Sanchez LS; Bekker JM; Ovadia B; Johengen MJ; Black SM; Fineman JR
    Pediatr Crit Care Med; 2004 May; 5(3):234-9. PubMed ID: 15115560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose phosphodiesterase inhibition improves responsiveness to inhaled nitric oxide in isolated lungs from endotoxemic rats.
    Klein A; Zils U; Bopp C; Gries A; Martin E; Gust R
    J Surg Res; 2007 Apr; 138(2):224-30. PubMed ID: 17275845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous dipyridamole enhances the effects of inhaled nitric oxide and prevents rebound pulmonary hypertension in piglets.
    Foubert L; De Wolf D; Mareels K; Van Belleghem Y; Reyntjens K; Mortier E; Van Nooten G
    Pediatr Res; 2002 Nov; 52(5):730-6. PubMed ID: 12409521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant effects of alkalosis on elevated pulmonary vascular resistance and vascular reactivity in lamb lungs.
    Moreira GA; O'Donnell DC; Tod ML; Madden JA; Gordon JB
    Crit Care Med; 1999 Sep; 27(9):1838-42. PubMed ID: 10507607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of lung phosphodiesterase improves responsiveness to inhaled nitric oxide in isolated-perfused lungs from rats challenged with endotoxin.
    Holzmann A; Manktelow C; Weimann J; Bloch KD; Zapol WM
    Intensive Care Med; 2001 Jan; 27(1):251-7. PubMed ID: 11280644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered endothelium-dependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow.
    Reddy VM; Wong J; Liddicoat JR; Johengen M; Chang R; Fineman JR
    Am J Physiol; 1996 Aug; 271(2 Pt 2):H562-70. PubMed ID: 8770097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.